Senna-Mint Waf



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 51.7%
Drug Use For Unknown Indication 15.2%
Thrombosis Prophylaxis 5.5%
Constipation 4.1%
Induction Of Anaesthesia 2.1%
Insomnia 2.1%
Pain 2.1%
Pharyngitis 2.1%
Systemic Lupus Erythematosus 2.1%
Abnormal Faeces 1.4%
Benign Prostatic Hyperplasia 1.4%
Bone Disorder 1.4%
Dyspepsia 1.4%
Hypertension 1.4%
Maintenance Of Anaesthesia 1.4%
Red Blood Cell Abnormality 1.4%
Thyroid Disorder 1.4%
Bipolar I Disorder 0.7%
Chronic Obstructive Pulmonary Disease 0.7%
Gastrooesophageal Reflux Disease 0.7%
Deep Vein Thrombosis 32.0%
Incontinence 8.0%
Bipolar I Disorder 4.0%
Cardiac Arrest 4.0%
Chronic Hepatic Failure 4.0%
Completed Suicide 4.0%
Confusional State 4.0%
Death 4.0%
Dyskinesia 4.0%
Dyspnoea 4.0%
Functional Gastrointestinal Disorder 4.0%
Macule 4.0%
Maternal Drugs Affecting Foetus 4.0%
Normal Newborn 4.0%
Prostatic Disorder 4.0%
Serotonin Syndrome 4.0%
Vomiting 4.0%
Concomitant
Product Used For Unknown Indication 40.1%
Constipation 9.7%
Pain 9.6%
Drug Use For Unknown Indication 6.2%
Nausea 5.3%
Multiple Myeloma 5.0%
Hypertension 3.2%
Depression 2.9%
Schizophrenia 2.8%
Prophylaxis 2.1%
Breast Cancer 1.9%
Anxiety 1.5%
Diabetes Mellitus 1.4%
Abdominal Pain 1.3%
Acute Myeloid Leukaemia 1.3%
Asthma 1.3%
Paroxysmal Nocturnal Haemoglobinuria 1.2%
Insomnia 1.1%
Supplementation Therapy 1.1%
Vomiting 1.1%
Death 9.7%
Pyrexia 8.3%
Dyspnoea 6.3%
Neutropenia 6.3%
Hallucination, Visual 5.6%
Haemoglobin Decreased 4.9%
Multiple Myeloma 4.9%
Myocardial Infarction 4.9%
Staphylococcal Infection 4.9%
Cerebrovascular Accident 4.2%
Colitis 4.2%
Fall 4.2%
Febrile Neutropenia 4.2%
Haematemesis 4.2%
Nausea 4.2%
Pain 4.2%
Thrombocytopenia 4.2%
Vomiting 4.2%
Asthenia 3.5%
Dizziness 3.5%